SCHEMBL7785138

SCHEMBL7785138

Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1OP(=O)(O)OP(=O)(O)O

nearest known ligand 0.85

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 1/20 0.85
RNASEL Q05823 6/20 0.75
P2RY2 P41231 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11776064 1.00 ADORA1 (0.85) ADORA1RNASELP2RY2
SCHEMBL23250438 0.99 ADORA1 (0.84) ADORA1RNASELP2RY2
SCHEMBL7706114 0.99 ADORA1 (0.84) ADORA1RNASELP2RY2
SCHEMBL23250436 0.99 ADORA1 (0.84) ADORA1RNASELP2RY2
SCHEMBL8167524 0.93 ADORA1 (0.74) ADORA1RNASELP2RY2
SCHEMBL29539212 0.93 ADORA1 (0.74) ADORA1RNASELP2RY2
SCHEMBL536567 0.93 ADORA1 (0.73) ADORA1RNASELP2RY2
SCHEMBL4370169 0.93 ADORA1 (0.73) ADORA1RNASELP2RY2
SCHEMBL30918598 0.93 ADORA1 (0.73) ADORA1RNASELP2RY2
SCHEMBL8509979 0.93 ADORA1 (0.85) ADORA1RNASELP2RY2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6252060-B1 COMPLEX CONTAINING DIDEOXYGUANOSINE NEXSTAR PHARMACEUTICALS, INC. 2001-06-26 US disclosed
US-5817638-A USING HYBRID NUCLEOSIDES NEXSTAR PHARMACEUTICALS, INC. (US) 1998-10-06 US disclosed
EP-0594677-A4 ANTIVIRAL LIPONUCLEOSIDES: TREATMENT OF HEPATITIS B VICAL INC (US) 1997-09-17 EP disclosed
EP-0594677-A1 ANTIVIRAL LIPONUCLEOSIDES: TREATMENT OF HEPATITIS B NeXstar Pharmaceuticals, Inc. (US) 1994-05-04 EP disclosed
WO-1993000910-A1 ANTIVIRAL LIPONUCLEOSIDES: TREATMENT OF HEPATITIS B VICAL, INC. (US) 1993-01-21 WO disclosed